Equipes et composantes labellisées
Clinical CoEN members (Montpellier University Hospital) | ||||
Short name | Team | Topic | Responsible/Contact | |
CHRU / A1 | Memory resource and research center, behavioral Neurology | Cognition and biomarkers for early diagnosis and prognosis of Alzheimer's disease | Audrey Gabelle | <link>audreygabelle@hotmail.com <link>a-gabelle@chu-montpellier.fr |
CHRU / A2 | Department of Neurology | Inflammatory diseases of the nervous system and diseases of the white matter (multiple sclerosis) | Pierre Labauge | <link>p-labauge@chu-montpellier.fr <link>labauge@yahoo.fr |
CHRU / A3 | Motor neuron clinic and pathologies neuromuscular, Motoneuron national reference center, | Genetics and therapy of amyotrophic lateral sclerosis. | William Camu | <link>w-camu@chu-montpellier.fr |
CHRU / A4 | Parkinson Disease Expert Center | Parkinson in the Elderly, Age related Tremor, Gait disorders | Christian Geny | <link>c-geny@chu-montpellier.fr |
CHRU / A5 | Center of competence for Huntington’s disease | Genetics and therapy of Huntington’s disease | Cecilia Marelli | <link>c-marelli@chu-montpellier.fr |
CHRU / A6 | Sleep disorders unit and Reference Centre narcolepsy | Epidemiology, clinical neurophysiology, biomarkers, and therapy of sleep disorders. | Yves Dauvilliers | <link>y-dauvilliers@chu-montpellier.fr |
CHRU / B1 | Gerontology department, Living Lab Frailty | Regional Evaluation Center of Frailty in the Elderly (CESAF) | Claude Jeandel | <link>c-jeandel@chu-montpellier.fr <link>claudejeandel@yahoo.fr |
CHRU / B2 | Regional center for balances and prevention of falls | Falls, sarcopenia, | Hubert Blain | <link>h-blain@chu-montpellier.fr |
CHRU / C1 | Functional Neurosurgery, | Dystonia, Parkinson and movement disorders deep brain stimulation therapies | Philippe Coubes | <link>p-coubes@chu-montpellier.fr |
CHRU / D1 | Department of Psychiatry, Expert center of bipolar disorder | Suicide behavior, genetics, bipolar troubles | Philippe Courtet | <link>p-courtet@chu-montpellier.fr |
CHRU / D2 | Department of Psychiatry, adult, University Service of Psychiatry adult | Schizophrenia: psychopathology in the treatment | Jean Philippe Boulenger, Delphine Capdevieille | <link>jp-boulenger@chu-montpellier.fr <link>d-capdevielle@chu-montpellier.fr |
CHRU / E1 | Laboratory of Biochemistry – Clinical Proteomics | Biomarkers of neurological pathologies (quantitative Proteomics) | Sylvain Lehmann | <link>s-lehmann@chu-montpellier.fr |
CHRU / E2 | Diagnostic using Neuroradiology, Department of Neuroradiology | Neurologic diseases and functional imaging | Alain Bonafe, V Costalat, N Menjot de Chamfleur | <link>a-bonafe@chu-montpellier.fr <link>v-costalat@chu-montpellier.fr <link>n-menjot_de_champfleur@chu-montpellier.fr |
CHRU / E3 | Department of nuclear medicine | Diagnosis of neurological pathologies and search of new tracers to sight neurological (markers of amyloid plaques, postsynaptic receptors of dopamine...) | Denis Mariano-Goulart | <link>d-mariano_goulart@chu-montpellier.fr |
CHRU / E4 | Genetic Department, Presymptomatic unit | Genetics, presymptomatic care | Pierre Sarda, Christine Coubes | <link>p-sarda@chu-montpellier.fr <link>c-coubes@chu-montpellier.fr |
CHRU / E5 | Medical Information Department (DIM) | Data management, research regulatory | Marie-Christine PICOT | <link>mc-picot@chu-montpellier.fr |
Research team CoEN members (Montpellier University, UM3, INSERM, CNRS) | ||||
Short name | Team | Topic | Responsible/Contact | |
Inserm U1061 / R1 | Affective disorders: bio-environmental risk and resilience | Epidemiology of neuropsychiatric disorders: physiological and (epi)genetic risk factors | Marie-Laure Ancelin | <link>marie-laure.ancelin@inserm.fr |
Inserm U1061 / R2 | Suicidal behaviour | Psychiatric vulnerability, suicidal behaviour | Philippe Courtet, Sébastien Guillaume | <link>philippe.courtet@univ-montp1.fr, <link>s-guillaume@chu-montpellier.fr |
Inserm U1061 / R3 | Age-related cognitive disorders | Multicentre research on vascular risk factors and cerebral aging. | Claudine Berr | <link>claudine.berr@inserm.fr |
Inserm U1061 / R4 | Sleep disorders | Epidemiology and mechanisms of disorders of sleep in the elderly | Yves Dauvilliers | <link>y-dauvilliers@chu-montpellier.fr |
Inserm U1061 / R5 | Platform of biostatistical modelling | Statistical modelling methods for the exploitation of the epidemiological and clinical data | Isabelle Carrière | <link>isabelle.carriere@inserm.fr |
Inserm U1183 / R1 | Genome and stem cell plasticity in development and ageing | Basic genetic and epigenetic mechanisms underlying tissue regeneration | Jean-Marc Lemaitre | <link>jean-marc.lemaitre@inserm.fr |
Inserm U1183 / R2 | Neural stem cells, MSC and neurodegenerative diseases | Neural Stem Cell, MSC and iPS in Neurodegenerative Diseases | Carole Crozet, Sylvain Lehmann | <link>carole.crozet@inserm.fr <link>sylvain.lehmann@inserm.fr |
UMR 1051 / R1 | Motoneurone disease: Neuroinflammation and therapy | Mechanisms and therapies for ALS | Cédric Raoul | <link>cedric.raoul@inserm.fr |
UMR 1051 / R2 | The microglial signature in ALS | Role of microglia and their molecular crosstalk with motoneurons in ALS | Florence Perrin | <link>florence.perrin@inserm.fr |
UMR 1051 / R3 | Neurodegeneration and degradation system | The Ubiquitine Proteasome system in neurodegeneration and cytoskeleton architecture | Pascale Bomont | <link>pascale.bomont@inserm.fr |
IGF / R1 | Neuroreceptor, dynamics, and function | Modulation of the mGlu and GABA receptor activity. | Jean-Philippe Pin, Laurent Prezeau | <link>jean-philippe.pin@igf.cnrs.fr <link>laurent.prezeau@igf.cnrs.fr |
IGF / R2 | Neuroproteomics and signaling of neurological and psychiatric disorders | Neuronal signaling networks, biomarkers of neurological diseases | Philippe Marin | <link>philippe.marin@igf.cnrs.fr |
IGF / R3 | New families of ion channels | Receptors, purinergic and neurodegenerative and inflammatory diseases | François Rassendren | <link>francois.rassendren@igf.cnrs.fr |
IGF / R4 | Normal and pathological neurobiology in drosophila | Molecular and cellular networks for Tau and other microtubule-associated proteins | Marie-Laure Parmentier | <link>Marie-Laure.Parmentier@igf.cnrs.fr |
IGF / R5 | Neural circuits and signal transduction | Molecular and cellular networks for dopamine and glutamate signals | Emmanuel Valjent | <link>emmanuel.valjent@igf.cnrs.fr |
IGF / R6 | Cell cycle clock genomics, C3G | Molecular and cellular networks | Frédéric Bienvenu | <link>frederic.bienvenu@igf.cnrs.fr |
Inserm U1198 / R1 | Brain aging and neurodegenerative pathologies | Study of brain aging in primates lemur Microcebus murinus (Mouse Lemur) | Jean-Michel Verdier | <link>jean-michel.verdier@univ-montp2.fr |
Inserm U1198 / R2 | Endogenous Neuroprotection in neurodegenerative diseases | Therapeutic approaches on non-transgenic models of Alzheimer's disease | Maurice Tangui | <link>maurice@univ-montp2.fr |
Inserm U1198 / R3 | Huntington's disease: Neurophysiopathology from Drosophila to mice | Neuroprotective properties of the peptide P42 from the huntingtin protein. | Florence Maschat | <link>florence.maschat@univ-montp2.fr |
Inserm U1198 / R4 | Longevity and vitality biodemography and Epidemiology of aging | Etiology of cerebral aging and neuropsychiatric disorders | Jean-Marie Robine, Tasnime Akbaraly | <link>robinejm@gmail.com <link>tasnime.akbaraly@inserm.fr |
IGH / R1 | Neurogenetics and Memory | Understanding of the physiological role of APP | Jean-Maurice Dura | <link>jean-maurice.dura@igh.cnrs.fr |
IGMM / R1 | Adenovirus : Receptors, Trafficking and Vectorology | Vector for gene transfer to the CNS | Eric J Kremer | <link>eric.kremer@igmm.cnrs.fr |
IGMM / R2 | Molecular Mechanisms of Apoptosis Regulation | Characterization of signaling pathways that control the survival/death fate of neurons. | Solange Desagher | <link>solange.desagher@igmm.cnrs.fr |
EA 4556 / R1 | Epsylon Laboratory EVOLVE team | To evaluate the question of psychosocial factors implied in the preservation or the damages of cognitive, physical functions and the psychological well-being in the elderly. | Marie-Christine Gely-Nargeot | <link>marie-christine.gely-nargeot@univ-montp3.fr |
Clinical CoEN members (Montpellier University Hospital) | ||||
Short name | Team | Topic | Responsible/Contact | |
CHRU / A1 | Memory resource and research center, behavioral Neurology | Cognition and biomarkers for early diagnosis and prognosis of Alzheimer's disease | Audrey Gabelle | <link>audreygabelle@hotmail.com <link>a-gabelle@chu-montpellier.fr |
CHRU / A2 | Department of Neurology | Inflammatory diseases of the nervous system and diseases of the white matter (multiple sclerosis) | Pierre Labauge | <link>p-labauge@chu-montpellier.fr <link>labauge@yahoo.fr |
CHRU / A3 | Motor neuron clinic and pathologies neuromuscular, Motoneuron national reference center, | Genetics and therapy of amyotrophic lateral sclerosis. | William Camu | <link>w-camu@chu-montpellier.fr |
CHRU / A4 | Parkinson Disease Expert Center | Parkinson in the Elderly, Age related Tremor, Gait disorders | Christian Geny | <link>c-geny@chu-montpellier.fr |
CHRU / A5 | Center of competence for Huntington’s disease | Genetics and therapy of Huntington’s disease | Cecilia Marelli | <link>c-marelli@chu-montpellier.fr |
CHRU / A6 | Sleep disorders unit and Reference Centre narcolepsy | Epidemiology, clinical neurophysiology, biomarkers, and therapy of sleep disorders. | Yves Dauvilliers | <link>y-dauvilliers@chu-montpellier.fr |
CHRU / B1 | Gerontology department, Living Lab Frailty | Regional Evaluation Center of Frailty in the Elderly (CESAF) | Claude Jeandel | <link>c-jeandel@chu-montpellier.fr <link>claudejeandel@yahoo.fr |
CHRU / B2 | Regional center for balances and prevention of falls | Falls, sarcopenia, | Hubert Blain | <link>h-blain@chu-montpellier.fr |
CHRU / C1 | Functional Neurosurgery, | Dystonia, Parkinson and movement disorders deep brain stimulation therapies | Philippe Coubes | <link>p-coubes@chu-montpellier.fr |
CHRU / D1 | Department of Psychiatry, Expert center of bipolar disorder | Suicide behavior, genetics, bipolar troubles | Philippe Courtet | <link>p-courtet@chu-montpellier.fr |
CHRU / D2 | Department of Psychiatry, adult, University Service of Psychiatry adult | Schizophrenia: psychopathology in the treatment | Jean Philippe Boulenger, Delphine Capdevieille | <link>jp-boulenger@chu-montpellier.fr <link>d-capdevielle@chu-montpellier.fr |
CHRU / E1 | Laboratory of Biochemistry – Clinical Proteomics | Biomarkers of neurological pathologies (quantitative Proteomics) | Sylvain Lehmann | <link>s-lehmann@chu-montpellier.fr |
CHRU / E2 | Diagnostic using Neuroradiology, Department of Neuroradiology | Neurologic diseases and functional imaging | Alain Bonafe, V Costalat, N Menjot de Chamfleur | <link>a-bonafe@chu-montpellier.fr <link>v-costalat@chu-montpellier.fr <link>n-menjot_de_champfleur@chu-montpellier.fr |
CHRU / E3 | Department of nuclear medicine | Diagnosis of neurological pathologies and search of new tracers to sight neurological (markers of amyloid plaques, postsynaptic receptors of dopamine...) | Denis Mariano-Goulart | <link>d-mariano_goulart@chu-montpellier.fr |
CHRU / E4 | Genetic Department, Presymptomatic unit | Genetics, presymptomatic care | Pierre Sarda, Christine Coubes | <link>p-sarda@chu-montpellier.fr <link>c-coubes@chu-montpellier.fr |
CHRU / E5 | Medical Information Department (DIM) | Data management, research regulatory | Marie-Christine PICOT | <link>mc-picot@chu-montpellier.fr |
Research team CoEN members (Montpellier University, UM3, INSERM, CNRS) | ||||
Short name | Team | Topic | Responsible/Contact | |
Inserm U1061 / R1 | Affective disorders: bio-environmental risk and resilience | Epidemiological and clinical cohort spirit | Marie-Laure Ancelin | marie-laure.ancelin@inserm.fr |
Inserm U1061 / R2 | Suicidal behaviour | Psychiatric vulnerability, suicidal behaviour | Philippe Courtet, Sébastien Guillaume | <link>p-courtet@chu-montpellier.fr, <link>philippe.courtet@univ-montp1.fr, s-guillaume@chu-montpellier.fr |
Inserm U1061 / R3 | Age-related cognitive disorders | Multicentre research on vascular risk factors and cerebral aging. | Claudine Berr | claudine.berr@inserm.fr |
Inserm U1061 / R4 | Sleep disorders | Epidemiology and mechanisms of disorders of sleep in the elderly | Yves Dauvilliers | y-dauvilliers@chu-montpellier.fr |
Inserm U1061 / R5 | Platform of biostatistical modelling | Statistical modelling methods for the exploitation of the epidemiological and clinical data | Isabelle Carrière | isabelle.carriere@inserm.fr |
Inserm U1183 / R1 | Genome and stem cell plasticity in development and ageing | Basic genetic and epigenetic mechanisms underlying tissue regeneration | Jean-Marc Lemaitre | jean-marc.lemaitre@inserm.fr |
Inserm U1183 / R2 | Neural stem cells, MSC and neurodegenerative diseases | Neural Stem Cell, MSC and iPS in Neurodegenerative Diseases | Carole Crozet, Sylvain Lehmann | carole.crozet@inserm.fr, sylvain.lehmann@inserm.fr |
UMR 1051 / R1 | Motoneurone disease: Neuroinflammation and therapy | Mechanisms and therapies for ALS | Cédric Raoul | cedric.raoul@inserm.fr |
UMR 1051 / R2 | The microglial signature in ALS | Role of microglia and their molecular crosstalk with motoneurons in ALS | Florence Perrin | florence.perrin@inserm.fr |
UMR 1051 / R3 | Deafness, tinnitus and therapies. |
| Jean-Luc Puel | Jean-luc.puel@inserm.fr |
UMR 1051 / R3 | Neurodegeneration and degradation system | The Ubiquitine Proteasome system in neurodegeneration and cytoskeleton architecture | Pascale Bomont | pascale.bomont@inserm.fr |
UMR 1051 / R4 | Deafness, tinnitus and therapies. | Study of the mechanisms of deafness and tinnitus to envision therapies. | Jean-Luc Puel | Jean-luc.puel@inserm.fr |
IGF / R1 | Neuroreceptor, dynamics, and function | Modulation of the mGlu and GABA receptor activity. | Jean-Philippe Pin, Laurent Prezeau | laurent.prezeau@igf.cnrs.fr |
IGF / R2 | Neuroproteomics and signs of neurological and psychiatric diseases | Biomarkers of neurological diseases | Philippe Marin | philippe.marin@igf.cnrs.fr |
IGF / R3 | New families of ion channels | receptors, purinergic and neurodegenerative and inflammatory diseases | François Rassendren | francois.rassendren@igf.cnrs.fr |
IGF / R4 | Normal and pathological neurobiology in drosophila | molecular and cellular networks for Tau and Huntingtin | Marie-Laure Parmentier | Marie-Laure.Parmentier@igf.cnrs.fr |
IGF / R5 | Neural circuits and signal transduction | Molecular and cellular networks for dopamine and glutamate signals | Emmanuel Valjent | emmanuel.valjent@igf.cnrs.fr |
IGF / R6 | Cell cycle clock genomics, C3G | molecular and cellular networks | Frédéric Bienvenu | frederic.bienvenu@igf.cnrs.fr |
IGF / R7 | Tracking diseases trajectories | Cell network plasticity in CNS diseases | Freddy Jeanneteau | Freddy.Jeanneteau@igf.cnrs.fr |
IGF / R8 | Physiopathology of the synaptic transmission | Study of the molecular processes involved in the physiological neuronal communication and deficiencies leading to neurodegenerative processes | Julie Perroy | Julie.Perroy@igf.cnrs.fr |
IGF / R9 | Cerebrovascular Mechanisms of Brain Disorders | Study of the relevance of cerebrovascular damage in i) the progression of neuro-inflammation and degeneration ii) the pathological brain-to-periphery exchanges | Nicola Marchi | nicola.marchi@igf.cnrs.fr |
Inserm U1198 / R1 | Brain aging and neurodegenerative pathologies | Study of brain aging in primates lemur Microcebus murinus (Mouse Lemur) | Jean-Michel Verdier | jean-michel.verdier@univ-montp2.fr |
Inserm U1198 / R2 | Endogenous Neuroprotection in neurodegenerative diseases | Therapeutic approaches on non-transgenic models of Alzheimer's disease | Maurice Tangui | maurice@univ-montp2.fr |
Inserm U1198 / R3 | Huntington's disease: Neurophysiopathology from Drosophila to mice | neuroprotective properties of the peptide P42 from the huntingtin protein. | Florence Maschat | florence.maschat@univ-montp2.fr |
Inserm U1198 / R4 | Life history of longevity and vitality | Etiology of cerebral aging from data from epidemiological cohort | Jean-Marie Robine | robinejm@gmail.com |
Inserm U1198 / R5 | Environmental impact on Alzheimer’s disease and related disorders | Impact of exogenous perturbations, on the etiology on AD and related diseases | Catherine Desrumaux, Laurent Givalois | catherine.desrumaux@univ-montp2.fr lgivalois@univ-montp2.fr |
IGH / R1 | Neurogenetics and Memory | Understanding of the physiological role of APP | Jean-Maurice Dura | jean-maurice.dura@igh.cnrs.fr |
IGH / R2 | Tubulin Code | Microtubule dynamics in Neurodegeneration | Krzysztof Rogowski | Krzysztof.Rogowski@igh.cnrs.fr |
IGMM / R1 | Adenovirus : Receptors, Trafficking and Vectorology | Vector for gene transfer to the CNS | Eric J Kremer | eric.kremer@igmm.cnrs.fr |
CRBM-CNRS/R1 | Signaling and cytoskeleton dynamics | Role of rho GTPases in brain development and neurodevelopmental diseases | Anne Debant | anne.debant@crbm.cnrs.fr |
IGMM / R2 | Molecular Mechanisms of Apoptosis Regulation | Characterization of signaling pathways that control the survival/death fate of neurons. | Solange Desagher | solange.desagher@igmm.cnrs.fr |
EA 4556 / R1 | Epsilon Laboratory EVOLVE team | To evaluate the question of psychosocial factors implied in the preservation or the damages of cognitive, physical functions and the psychological well-being in the elderly. | Marie-Christine Gely-Nargeot | marie-christine.gely-nargeot@univ-montp3.fr |
EFS/R1 | Diagnostic and therapeutic innovation | Study of chronic infection (prion, Zika, VIH) | Chantal Fournier-Wirth | Chantal.Fournier@efs.sante.fr |